SF767人腦瘤細胞、SF76
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2025/4/24 14:51:43
- 訪問次數(shù) 85
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息，謝謝!
SF767 人腦瘤細胞
Catalogue No.: C748
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%H-DMEM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a T25 flask | 2X106 |
| Manual | 1 copy |
SCLC cases, respectively, and CD8+ TILs were present in 59% of SCLC samples (32). Hui Yuetal. reported that the overall prevalence of PD-L1 expression was 16.5% in tumor cells and 44.8% in tumor-in?ltrating immune cells in their SCLC cohort (33). In our study, PD-L1 was expressed on tumor cells in two thymic NEC cases (2/7, 28.6%) and on tumor-in?ltrating immune cells in three thymic NEC cases (3/7, 42.9%),which are comparable with the frequency of PD-L1
采購中心
化工儀器網(wǎng)